Mission Statement
Clinical Trials on time and on budget
Focus Areas
Related Clinical Trials
300 total trialsEfficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
NCT07364396 • Not yet recruiting • InterventionalStudy to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
NCT07363460 • Recruiting • InterventionalThe Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
NCT07340463 • Recruiting • InterventionalBCMA-CD19 cCAR T for the Treatment of Refractory Lupus
NCT07328581 • Not yet recruiting • InterventionalDapagliflozin in Active Lupus Nephritis
NCT07323524 • Not yet recruiting • InterventionalAn Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT07236762 • Not yet recruiting • InterventionalSafety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
NCT07225387 • Recruiting • InterventionalA Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
NCT07201129 • Not yet recruiting • InterventionalThe Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis
NCT07130448 • Not yet recruiting • ObservationalA Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
NCT07123519 • Not yet recruiting • InterventionalContact Information
Organization Stats
1
Focus Areas300
Related TrialsSubmitted 6 months ago